During the past decade, Nzoz Heureka conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nzoz Heureka" are "Overactive Bladder" (4 trials), "Atrial Fibrillation" (1 trials), "Prevention of Stroke or Systemic Embolism" (1 trials) and "Urinary Incontinence" (1 trials). Many other conditions were trialed in "Nzoz Heureka" in a lesser frequency.

Most popular intervention types in "Nzoz Heureka" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Vibegron" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nzoz Heureka" are 3 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Nzoz Heureka". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nzoz Heureka, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nzoz Heureka, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".